These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16384811)

  • 21. Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine.
    Jagadheesan K; Muirhead D
    Aust N Z J Psychiatry; 2004 Jul; 38(7):560. PubMed ID: 15255830
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
    Kudo T
    Seishin Shinkeigaku Zasshi; 2007; 109(7):657-63. PubMed ID: 17969953
    [No Abstract]   [Full Text] [Related]  

  • 23. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot, open-label safety study of quetiapine for treatment of moderate psychotic agitation in the emergency setting.
    Currier GW; Trenton AJ; Walsh PG; van Wijngaarden E
    J Psychiatr Pract; 2006 Jul; 12(4):223-8. PubMed ID: 16883147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease.
    Edlinger M; Seppi K; Fleischhacker W; Hofer A
    Int Clin Psychopharmacol; 2013 Jul; 28(4):214-6. PubMed ID: 23652781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight gain--as possible predictor of metabolic syndrome.
    Grahovac T; Ružić K; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
    Psychiatr Danub; 2011 Mar; 23(1):105-7. PubMed ID: 21448110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options.
    Lesser JM; Hughes S
    Geriatrics; 2006 Dec; 61(12):14-20. PubMed ID: 17184138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
    Keller R; Mongini F
    Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of the agitation of late-life psychosis and Alzheimer's disease.
    Salzman C
    Eur Psychiatry; 2001 Jan; 16 Suppl 1():25s-28s. PubMed ID: 11520475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.
    Weintraub D; Katz IR
    Psychiatr Clin North Am; 2005 Dec; 28(4):941-83, ix-x. PubMed ID: 16325736
    [No Abstract]   [Full Text] [Related]  

  • 31. Aseptic gingivitis related to quetiapine hemifumarate.
    Gahr M; Kölle MA; Freudenmann RW; Schönfeldt-Lecuona C
    Pharmacopsychiatry; 2013 Jan; 46(1):39-40. PubMed ID: 22915485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of quetiapine in children and adolescents.
    Findling RL
    J Clin Psychiatry; 2002; 63 Suppl 13():27-31. PubMed ID: 12562144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptics and alternative treatments. Management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions.
    Wragg RE; Jeste DV
    Psychiatr Clin North Am; 1988 Mar; 11(1):195-213. PubMed ID: 2898133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quetiapine and leukopenia.
    Clark N; Weissberg E; Noel J
    Am J Psychiatry; 2001 May; 158(5):817-8. PubMed ID: 11329413
    [No Abstract]   [Full Text] [Related]  

  • 35. Parkinsonism and akathisia with quetiapine: three case reports.
    Bharadwaj R; Grover S
    J Clin Psychiatry; 2008 Jul; 69(7):1189-91. PubMed ID: 18687022
    [No Abstract]   [Full Text] [Related]  

  • 36. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
    Dan A; Bharadwaj R; Grover S
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404
    [No Abstract]   [Full Text] [Related]  

  • 38. Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing.
    Nemeroff CB; Kinkead B; Goldstein J
    J Clin Psychiatry; 2002; 63 Suppl 13():5-11. PubMed ID: 12562141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New-onset diabetes mellitus associated with quetiapine.
    Procyshyn RM; Pande S; Tse G
    Can J Psychiatry; 2000 Sep; 45(7):668-9. PubMed ID: 11056833
    [No Abstract]   [Full Text] [Related]  

  • 40. Quetiapine in adolescent psychosis.
    Healy E; Subotsky F; Pipe R
    J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1329. PubMed ID: 10560217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.